The global Infertility Market Share is anticipated to grow at CAGR of 12.84 % and will reach a valuation of USD 3.65 billion during the forecast period 2022-2030. Infertility is a form of medical condition that is observed both in women and men. Simply put, it is an individual’s inability of reproducing naturally. Some of the common causes of infertility in men include abnormal sperm function or production, genetic problems, diabetes mellitus, DNA damage, issues with delivery of sperm, overexposure to specific environmental factors, damage associated to cancer and more. Here the environmental factors include exposure to pesticides, radiation, alcohol, smoking, taking certain medications and regular exposure to heat. On the other hand, the common causes of infertility in women include ovulation disorders, cervical or uterine abnormalities, fallopian tube blockage or damage, endometriosis, early menopause and pelvic adhesions. The other causes include cancer and its associated treatment and other conditions such as genetic abnormalities, absence of menstruation, ruptured appendicitis, polycystic ovary syndrome, and medical conditions related to delayed puberty. There are a couple of risk factors related to infertility both in women and men. These include age, tobacco use, alcohol use, being overweight, being underweight, exercise issues, increasing age at marriage, sedentary lifestyle, stress, hormonal disorders, anabolic steroid use, abdominal surgery and more.

There are many factors that is driving the growth of the infertility market. Some of these factors as per the Market Research Future (MRFR) report include declining rate of fertility, increasing number of fertility clinics, advancements in technology, increasing grants, funds and public-private investments, lifestyle disorders, increasing awareness about infertility, accessibility of advanced infertility treatment devices and treatment option and advent of various assisted reproductive techniques. On the contrary, factors such as complications and risk related to infertility treatment, soaring procedural cost, unsupportive government regulations, poor efficacy of infertility treatment, social taboos concerning the treatment and side effects of drug therapy is likely to act as major barriers in the infertility market growth.

Key Players

Key Infertility Market Players include EMD Serono, Inc., Bayer Healthcare, Aetna Inc., Androvia LifeSciences, Zydus Cadila Healthcare Ltd, Andrology Solutions, SCSA Diagnostics, Inc., Halotech DNA and others.

Market Segmentation

Market Research Future report offers an all-inclusive segmental analysis of the Infertility Market Trends on the basis of sex, diagnosis, drugs and techniques.

Based on sex, it is segmented into females and males. Of these, females will have the largest share in the infertility market over the assessment period owing to accessibility of a wide variety of treatment processes and decrease in female fertility.

Based on diagnosis, the infertility market is segmented into men diagnostic tests (testicular biopsy, genetic testing, semen analysis and others), women diagnostic tests (hysterosalpingography, ovulation testing, laparoscopy, hysteroscopy and others) and general diagnostic tests (imaging, microscopic analysis, hormone testing, genetic testing and others).

Based on drugs, it is segmented into hormone treatment, serophene, letrozole, clomiphene citrate and others.

Based on techniques, the infertility market is segmented into surgery, intrauterine insemination and assisted reproductive technology (ART). Surgery is further segmented into tubal surgeries, hysteroscopic or laparoscopic surgery and others. Of these, assisted reproductive technology (ART) will lead the market owing to advancements in technology and lifestyle disorders.

Regional Analysis

Based on region, the Infertility Market covers growth opportunities and latest trends across North America, Europe, Asia Pacific and Middle East and Africa. Of these, North America will dominate the market with the US being the largest contributor in this region owing to favorable reimbursement scenario, high income and rising pool of awareness. The infertility market in Europe will have the second largest share and the major contributors in this region include the UK, France and Germany. The key factor that is droving the growth of the market in this region is the technological advancements being made in the infertility treatment. The infertility market in the APAC region will be the fastest growing, dominated by India and China. The factors that are driving the growth of the market here include highest male infertility rate in South Asia and large population having unmet needs.

Feb 2019- Scientists have discovered a novel robotic sensor technology which can be utilized for measuring hormones that affect sexual development, menstruation and fertility cheaply and quickly than the current techniques. This technology uses a RAPTER device that will provide clinicians with a more accurate and faster hormone pulsatility diagnosis which affects the reproductive health and result in more targeted and better treatments in case of women.

Global Infertility Market Size, Analysis By 2023 | Top Companies EMD Serono, Inc., Bayer Healthcare, Aetna Inc., Androvia LifeSciences

Related Report-

Contraceptive Pills Market Research Report- Global Forecast To 2027      

Auto-Injectors Market Research Report- Forecast to 2027

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013